Vericel VCEL
NASDAQ VCEL
$40.15 +0.71 (+1.80%)
At close: Oct 2, 2026 · 4:00 PM EDT

Vericel (VCEL) Gains from Sales and Divestitures (2014 - 2021)

Updated

Vericel (VCEL) posted Gains from Sales and Divestitures of $22,000 for Q1 2021.

Analysis

Vericel (VCEL) Gains from Sales and Divestitures (2014 - 2021) Analysis & Trends

For FY2020, Vericel's Gains from Sales and Divestitures came in at -$30,000.

  • In prior years, Vericel's Gains from Sales and Divestitures was -$22,000 in FY2018 and $115,000 in FY2017.
  • The Q1 2021 figure stands as the highest quarterly Gains from Sales and Divestitures since Q4 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Vericel 2.05 Bn 1.47 Bn 56.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 22,000.00
Jun 30, 2020 -30,000.00
Dec 31, 2018 1,000.00
Jun 30, 2018 -1,000.00
Mar 31, 2018 -22,000.00
Dec 31, 2017 115,000.00
Mar 31, 2015 35,000.00
Dec 31, 2014 -139,000.00
API Access

Vericel Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=VCEL&period=max&api_key=YOUR_API_KEY